Stoneridge Investment Partners’s Abbott ABT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.29M Sell
12,214
-8,480
-41% -$774K 0.85% 22
2026
Q1
$2.13M Buy
+20,694
New +$2.34M 1.54% 15
2023
Q1
Sell
-2,150
Closed -$236K 96
2022
Q4
$236K Buy
+2,150
New +$223K 0.13% 90
2017
Q1
Sell
-550,856
Closed -$21.2M 306
2016
Q4
$21.2M Buy
550,856
+178,509
+48% +$7.08M 2.88% 2
2016
Q3
$15.7M Buy
372,347
+81,228
+28% +$3.48M 2.28% 2
2016
Q2
$11.4M Buy
+291,119
New +$11.6M 1.71% 7
2014
Q4
Sell
-38,833
Closed -$1.61M 253
2014
Q3
$1.61M Buy
+38,833
New +$1.64M 0.24% 129
2013
Q4
Sell
-118,465
Closed -$3.93M 206
2013
Q3
$3.93M Buy
+118,465
New +$4.16M 0.86% 39

Other funds holding ABT

Stoneridge Investment Partners's ABT Position: Q2 2026 in Review

Stoneridge Investment Partners reduced its Abbott (ABT) stake by 41% in Q2 2026, selling an estimated $774K and leaving 12,214 shares worth $1.29M. The position accounts for 0.85% of the portfolio, ranked #22.

Stoneridge Investment Partners first reported a position in ABT in Q3 2013 and has held it in 8 quarters since. The position peaked at $21.2M in Q4 2016. 2,975 funds tracked by Wall St. Rank hold ABT as of Q2 2026.

  • Stoneridge Investment Partners held 12,214 shares of Abbott worth $1.29M as of Q2 2026.
  • Stoneridge Investment Partners sold 8,480 Abbott shares in Q2 2026, an estimated $774K.
  • Abbott made up 0.85% of Stoneridge Investment Partners's portfolio in Q2 2026, its #22 holding.
  • Stoneridge Investment Partners first reported a position in Abbott in Q3 2013 and has held it in 8 quarters since.
  • Stoneridge Investment Partners's Abbott position peaked at $21.2M in Q4 2016.
  • 2,975 funds tracked by Wall St. Rank held Abbott as of Q2 2026.

Based on Stoneridge Investment Partners's 13F filing for Q2 2026, filed 6 Aug 2026.